Middle East & Africa Mycoplasma Testing Market Size & Outlook
Middle East & Africa mycoplasma testing market, 2018-2030 (US$M)
Related Markets
MEA mycoplasma testing market highlights
- The MEA mycoplasma testing market generated a revenue of USD 36.4 million in 2023.
- The market is expected to grow at a CAGR of 8.8% from 2024 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 36.4 million |
| Market revenue in 2030 | USD 65.6 million |
| Growth rate | 8.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Kits & Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.9% of the global mycoplasma testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 528.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mycoplasma Testing Market Scope
Mycoplasma Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa mycoplasma testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 54.4% in 2023. Horizon Databook has segmented the Middle East & Africa mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
In the Middle East and Africa, the demand for mycoplasma testing is rising due to the expanding biopharmaceutical and biotechnology industries of the region. Countries such as Saudi Arabia, the UAE, and South Africa are investing heavily in healthcare infrastructure and research, necessitating stringent quality control measures to ensure the safety & efficacy of biological products.
The growth of local pharmaceutical manufacturing and the adoption of biosimilars and biologics further drive the need for reliable mycoplasma testing. Government initiatives to promote healthcare innovation and attract international biotech companies are also key factors boosting the growth. These initiatives often include implementing rigorous regulatory standards aligned with global practices, which emphasize the importance of mycoplasma testing.
In addition, partnerships with international firms bring advanced technologies and expertise to the region, enhancing local testing capabilities. As a result, mycoplasma testing is becoming increasingly integral to maintaining high standards in biomedical research and production across the Middle East and Africa.
Reasons to subscribe to Middle East & Africa mycoplasma testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa mycoplasma testing market databook
-
Our clientele includes a mix of mycoplasma testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa mycoplasma testing market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA mycoplasma testing market size, by country, 2018-2030 (US$M)
Middle East & Africa Mycoplasma Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
